The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 546.00
Bid: 542.00
Ask: 550.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.476%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 546.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MuCell Extrusion LLC Obtains an Exclusive License

14 Aug 2012 07:00

RNS Number : 9308J
Zotefoams PLC
14 August 2012
 



14 August 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

MuCell Extrusion LLC Obtains an Exclusive License for Styron's

Extruded Styrenic Foam Sheet Patent Portfolio, including Polystyrene, ABS and SAN

 

MuCell Extrusion LLC and Styron (Berwyn, Pennsylvania) have concluded an agreement for MuCell Extrusion LLC to acquire access to Styron's patent portfolio for extrusion of Styrenic resins. This agreement gives MuCell Extrusion and its customers exclusive rights to the Styron patents related to Sheet technology for a wide variety of applications.

 

This agreement creates a significant strategic alliance between two companies with leading experience in the successful development and application of physical blowing agents to produce superior foamed products.

 

The combination of Styron's CO2RE™ technology and MuCell's expertise around technology and hardware is expected to help customers improve their competitive advantage in a shorter timeframe. Sheet for thermoforming, FFS, roll stock, paneling and high volume packaging will all see significant cost reductions by applying this technology.

 

 "CO2RE™ is a patented plastic foaming technology that produces polystyrene sheets with a foamed core layer using physical blowing agents," said John Case, Styrenics Global Marketing Manager, Styron. "The technology provides a good opportunity for the packaging market, where for example dairy and food service industries can improve their sustainability by reducing the density and weight of their product packaging. It also provides benefits in reduced energy and reduced raw material usage, as well as lower packaging waste disposable tax in the EU."

 

"MuCell provides expertise in Process and Equipment development, and Styron offers formulation expertise in resins. We believe this combination will bring significant benefits to our customers," said Mark Lindenfelzer, President of MuCell. "The combination of our own patents and intellectual property, and Styron's patents now gives our customers the opportunity to apply the most advanced foaming technology in their products," he said.

 

About MuCell Technology

MuCell technology is based on the direct injection of atmospheric gas (N2 or CO2) in its supercritical state. MuCell has applied this technology to most plastic materials and processes. Rigid sheet, low-density flexible sheet, Blown film, Cast film, pipe/tubing/profile, and blow molding manufacturing processes are all current applications using MuCell technology. MuCell's innovative and accessible technology brings significant material weight-savings and cost reduction opportunities, without compromising physical product performance.

 

Earlier this year, Dow Chemical and MuCell reached an agreement for MuCell to acquire exclusive rights to Dow's patent portfolio for flat sheet resin technology, and more recently Dow's patents for Foam Film technology.

 

The corporate headquarters of MuCell Extrusion LLC are located at 212 West Cummings Park, Woburn, MA 01810. MuCell Extrusion is a wholly owned subsidiary of Zotefoams plc, UK (ZTF on LSE). For more information, please visit www.mucellextrusion.com.

 

About Styron

Styron is a leading global materials company and manufacturer of plastics, latex and rubber, dedicated to collaborating with customers to deliver innovative and sustainable solutions. Styron's technology is used by customers in industries such as home appliances, automotive, building & construction, carpet, consumer electronics, consumer goods, electrical & lighting, medical, packaging, paper & paperboard, rubber goods and tires. Styron had approximately $6 billion in revenue in 2011, with 20 manufacturing sites around the world, and 2100 employees. More information can be found at www.styron.com.

 

###

 

For Styron editorial information please contact:

Donna St. Germain, Styron

Tel. +1 610 240 3307

stgermain@styron.com

 

 

For information on MuCell Extrusion LLC and Zotefoams plc contact:

 

Zotefoams plc

Clifford Hurst or David Stirling

+44 20 8664 1600

 

FTI Consulting

John Dineen / Victoria Foster Mitchell

+44 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKNDDFBKDPFD
Date   Source Headline
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Results
16th Jun 20205:05 pmRNSHolding(s) in Company
12th Jun 20203:25 pmRNSDirector/PDMR Shareholding
8th Jun 20202:06 pmRNSResult of the 2020 Annual General Meeting
2nd Jun 20208:00 amRNSOperational and Trading Update
22nd May 202012:07 pmRNSSecond Price Monitoring Extn
22nd May 202012:02 pmRNSPrice Monitoring Extension
14th May 20203:48 pmRNSIssue of Equity
14th May 20203:15 pmRNSDirector/PDMR Shareholding
6th May 20207:00 amRNS2019 Annual Report and Notice of the 2020 AGM
28th Apr 20204:39 pmRNSDisclosure of rights attached to equity shares
22nd Apr 20203:51 pmRNSDirector/PDMR Shareholding
16th Apr 202012:39 pmRNSDirector/PDMR Shareholding
14th Apr 20202:41 pmRNSDirector/PDMR Shareholding
8th Apr 20204:19 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary Results
1st Apr 20207:00 amRNSNotice of Results
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNS2019 Summary, COVID-19 and Current Trading Update
23rd Mar 20207:00 amRNSDelayed Preliminary Results
19th Mar 20208:40 amRNSDirectorate Change
17th Mar 20209:49 amRNSHolding(s) in Company
12th Mar 20204:11 pmRNSDirector/PDMR Shareholding
10th Mar 20204:30 pmRNSNotice of Results
27th Feb 20203:00 pmRNSDirector Declaration
12th Feb 20209:24 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSYear-End Trading Update
16th Jan 20203:33 pmRNSHolding(s) in Company
13th Jan 20204:21 pmRNSDirector/PDMR Shareholding
27th Dec 20199:03 amRNSHolding(s) in Company
17th Dec 20199:34 amRNSDirector/PDMR Shareholding
13th Dec 20198:41 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSHolding(s) in Company
26th Nov 201910:39 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSDirector/PDMR Shareholding
15th Oct 20192:50 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20199:48 amRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
15th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20194:31 pmRNSHolding(s) in Company
9th Oct 20192:37 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSNew technology for recyclable packaging
8th Oct 20197:00 amRNSAppointment of Joint Broker
3rd Oct 20197:00 amRNSTrading Update
1st Oct 201911:47 amRNSDirector Declaration
16th Sep 20193:39 pmRNSDirector/PDMR Shareholding
6th Sep 201912:07 pmRNSSecond Price Monitoring Extn
6th Sep 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.